Pneumoconiosis treatment

Pneumoconiosis is a pulmonary fungi-infected disease caused by fungi, which involves a number of aspects, as described below: An allergy bronchial pulmonary acrosis (ABPA) patients may also experience acute symptoms such as asthma, coding, sepsis, and a significant increase in serum Ige levels. Auxiliary examination: Visual examination: for example, chest X-rays, CTs, etc., can show unusual manifestations of lung impregnation, bronchial extension, etc. Laboratory examinations, including blood routines, blood, biochemistry, sero-Ige tests, etc., help to assess the overall condition of patients and their immune function. Pathological examination: The presence of fungus can be detected by means of abdomen, bronchoscopy or sapling. Diagnosis criteria: bronchial pulmonary acrosis can be diagnosed, based on clinical performance of the patient, visualization and laboratory results, in conjunction with pathological examinations. Analytic bronchial pulmonary acrosis (ABPA) must also be diagnosed according to specific diagnostic criteria such as the Rosenberg Patterson standard, the Greenberger standard, etc. General treatment Rest and nutrition: Patients shall ensure adequate rest and avoid overwork. The diet is light, digestive and nutritious, such as chicken, fish, etc., to supplement the nutrients required by the body. Environmental improvements: Maintain good indoor ventilation and reduce exposure to aroma. Avoid exposure to known allergies to avoid aggravating respiratory symptoms. 2. Drug treatment Anti-foulbacterial drugs: the primary drug for bronchial pulmonary acrosis that kills or inhibits fungi growth by interfering with the synthesis of fungi cell walls or influencing their metabolic processes. Common drugs include Ictarconium, Volcomconium, etc., and specific doses and treatments need to be adapted to the patient ‘ s severity and tolerance. Immuno-modified treatment: to increase the body ‘ s immunity against pathogen infections. It may involve the use of immunostatics, such as cyclic steroids, or drugs that reduce immune reactions, such as cortical steroids, subject to medical guidance. Treatment of illnesses: If the patient suffers from symptoms such as tungsten, cough, etc., the treatment of the disease can be done with the use of singing. In the case of persons suffering from haemorrhage, hemorrhagic drugs are used or surgically treated. Surgery bronchial embolism: applies to patients with repeated or large amounts of coding, for the purpose of stopping the bleeding of bronchial arteries through catheter intervention techniques. Pneumoctomy: In cases where the pathology is widespread, the pulmonary function is severely impaired or the treatment of drugs is ineffective, pulmonary surgery may be considered in order to completely remove the stove. 4. Other assistive treatment. Pulmonary function exercise: including deep breath, cough exercise, etc., contributes to the improvement of lung activity and aerobics and to the reduction of respiratory discomfort due to fungus attacks. Oxygen therapy: In cases of respiratory insufficiency, high oxygen concentrations can be given to correct hypoxiaemia and to alleviate respiratory distress. Medical care in China: Some patients can be treated with Chinese medicine to help improve their lungs ‘ discomfort. However, it should be noted that Chinese medical treatment is conducted under the guidance of a professional physician. 3. After prognosis The prognosis of bronchial pulmonary acrosis is generally good, but poor if there are serious complications such as respiratory disorders and haematoma. Thus, early diagnosis and timely treatment are essential to improve patient prognosis. In conclusion, bronchial pulmonary acrosis involves clinical performance, assistive examinations, diagnostic criteria, treatment methods and prognosis. In the course of treatment, appropriate treatment options should be selected on the basis of the patient ‘ s specific circumstances, and changes in the patient ‘ s condition and adverse reactions should be closely monitored. At the same time, strengthening patients ‘ health education and lifestyle interventions are important measures to improve the effectiveness and predictability of treatment.